STXS Stereotaxis

Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020

Stereotaxis to Report First Quarter 2020 Financial Results on May 5, 2020

ST. LOUIS, April 30, 2020 (GLOBE NEWSWIRE) -- (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2020 first quarter on Tuesday, May 5, 2020 before the open of the U.S. financial markets. The Company will host a conference call and webcast at 10:00 a.m. Eastern Time that day to discuss the Company’s results and corporate developments.

What: Stereotaxis first quarter financial results conference call
   
When: Tuesday, May 5, at 10:00 a.m. Eastern Time (7:00 a.m. PT)
   
Dial In Number: To access the live call, dial (US and Canada) or (International) and give the participant pass code 9794597.
   
Webcast: To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at
   
Call Replay: A phone replay of the call will be available for one week beginning approximately two hours following the end of the call through May 12, 2020. To access a replay of the conference call, dial 1-855-859-2056 (US and Canada) or 1-404-537-3406 (International) and give the participant pass code 9794597.



About Stereotaxis

is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The core components of Stereotaxis’ systems have received regulatory clearance in the United States, European Union, Japan, Canada, China, and elsewhere. For more information, please visit .

Company Contacts:

David L. Fischel

Chairman and Chief Executive Officer

Kimberly Peery

Chief Financial Officer

314-678-6100

EN
30/04/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Stereotaxis

 PRESS RELEASE

Stereotaxis Reports 2025 First Quarter Financial Results

Stereotaxis Reports 2025 First Quarter Financial Results ST. LOUIS, May 12, 2025 (GLOBE NEWSWIRE) -- (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the first quarter ended March 31, 2025. “We’ve started the year with solid execution on key commercial and innovation efforts,” said David Fischel, Chairman and CEO. “This is a milestone rich year in which we are beginning to demonstrate the tangible reality and commercial impact of our comprehensive innovation strategy.” “Key ...

 PRESS RELEASE

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, ...

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025 ST. LOUIS, April 22, 2025 (GLOBE NEWSWIRE) -- (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 first quarter on Monday, May 12, 2025 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. EST that day to discuss the Company’s results and corporate developments. What:Stereotaxis first quarter 2025 financial results conference call  ...

 PRESS RELEASE

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System...

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025 GenesisX pairs clinical capability with broad accessibility in surgical robotics ST. LOUIS, April 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced today it will host a live demonstration of the GenesisX Robotic System at this year’s Heart Rhythm Symposium (HRS), taking place April 24 – 27 in San Diego, CA. This marks the first live, public demonstration of GenesisX, offering a glimpse to HRS ...

 PRESS RELEASE

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Confe...

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program ST. LOUIS, March 19, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that NVIDIA highlighted Stereotaxis’ technology at NVIDIA GTC and has accepted Stereotaxis into the NVIDIA Connect program. NVIDIA GTC (GPU Technology Conference) is a global artificial intelligence (AI) conference that brings together engineers, researchers, and inventors working to p...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch